On August 9th, the Sci Tech Innovation Forum on Nucleic Acid Technology and the launch ceremony of the "Nankai University Quanhecheng Genomic Nucleic Acid Technology Joint Laboratory" were held in Tianjin Economic Development Zone. The conference focused on the nucleic acid drug industry, inviting industry experts and entrepreneurs to have in-depth discussions on the current status and trends of industry development, technological innovation platforms, and how to accelerate the transformation and application of scientific and technological achievements. It provided a rich and diverse platform for exchange for the attending guests.

On the forum, the "Nankai University Quanhecheng Genomic Nucleic Acid Technology Joint Laboratory" was officially launched. The joint laboratory will be located on the 15th floor south of Tianjin International Biomedical Joint Research Institute, jointly built by Nankai University, Quanhecheng Technology, and Tianjin Pharmaceutical Joint Institute.

It is reported that the joint laboratory will actively build a public service platform for nucleic acid universal technology, dedicated to the basic research and application transformation of genomic nucleic acid technology, especially strengthening the exploration of the potential value of emerging nucleic acid technologies in disease treatment. The joint laboratory hopes to make breakthroughs in key technologies and product development of nucleic acid drugs, accelerate the transformation of scientific research achievements into new quality productivity, strive to cultivate and build a first-class nucleic acid drug research team, and jointly promote comprehensive technical cooperation between enterprises and schools in the field of nucleic acid drugs.